NCT01594242View on ClinicalTrials.gov

Autophagy Induction After Bortezomib for Myeloma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 10, 2012

Primary Completion Date

March 2, 2015

Study Completion Date

March 2, 2015

Conditions
Multiple Myeloma
Interventions
DRUG

Bortezomib

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01594242 - Autophagy Induction After Bortezomib for Myeloma | Biotech Hunter | Biotech Hunter